Inositol phosphatase SHIP1 is a primary target of miR-155
Open accessThe DOI matches its Crossref record; 50 of the 51 references it cites were found in a registry or an index.
Abstract
MicroRNA-155 (miR-155) has emerged as a critical regulator of immune cell development, function, and disease. However, the mechanistic basis for its impact on the hematopoietic system remains largely unresolved. Because miRNAs function by repressing specific mRNAs through direct 3′UTR interactions, we have searched for targets of miR-155 implicated in the regulation of hematopoiesis. In the present study, we identify Src homology-2 domain-containing inositol 5-phosphatase 1 (SHIP1) as a direct target of miR-155, and, using gain and loss of function approaches, show that miR-155 represses SHIP1 through direct 3′UTR interactions that have been highly conserved throughout evolution. Repression of endogenous SHIP1 by miR-155 occurred following sustained over-expression of miR-155 in hematopoietic cells both in vitro and in vivo, and resulted in increased activation of the kinase Akt during the cellular response to LPS. Furthermore, SHIP1 was also repressed by physiologically regulated miR-155, which was observed in LPS-treated WT versus miR-155 −/− primary macrophages. In mice, specific knockdown of SHIP1 in the hematopoietic system following retroviral delivery of a miR-155-formatted siRNA against SHIP1 resulted in a myeloproliferative disorder, with striking similarities to that observed in miR-155-expressing mice. Our study unveils a molecular link between miR-155 and SHIP1 and provides evidence that repression of SHIP1 is an important component of miR-155 biology.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Furthermore, miR-155 targets mRNAs coding for additional molecules involved in suppressing the inflammatory response including, SHIP1 [26] and SOCS1 [27], leading to increased pro-inflammatory gene expression.”
From Microglia specific deletion of miR-155 in Alzheimer’s disease mouse models reduces amyloid-β pathology but causes hyperexcitability and seizures (2023) · cites this paper as [26]
In the citing paper
“miR-155 targets Src homology-2 domain-containing inositol 5-phosphatase 1 (SHIP1), leading to activation of kinase Akt during the cellular response to LPS [158]”
From MicroRNAs as Regulators of Phagocytosis (2022) · cites this paper as [158]
Citations
Cites
Lewis, B. P., Burge, C. B., & Bartel, D. P. (2005) · Cell · doi:10.1016/j.cell.2004.12.035 · Cited by 11,855 · cited 2×
“SHIP1 3 UTR sequences from human, mouse, rat and dog were obtained and aligned with each other and with the miR-155 seed region using TargetScan (24).”
BackgroundMethodTaganov, K. D., Boldin, M. P., Chang, K.-J., & Baltimore, D. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0605298103 · Cited by 4,317
Self-citationA microRNA polycistron as a potential human oncogene
He, L., Thomson, J. M., Hemann, M. T., Hernando-Monge, E., Mu, D., Goodson, S., Powers, S., Cordon-Cardo, C., Lowe, S. W., Hannon, G. J., et al. (2005) · Nature · doi:10.1038/nature03552 · Cited by 3,483
Widespread changes in protein synthesis induced by microRNAs
Selbach, M., Schwanhäusser, B., Thierfelder, N., Fang, Z., Khanin, R., & Rajewsky, N. (2008) · Nature · doi:10.1038/nature07228 · Cited by 3,429 · cited 1×
“To date, several putative targets of miR-155 have been predicted through bioinformatic and proteomic approaches (46), indicating that there may be great complexity underlying miR-155 function.”
BackgroundMicroRNA-155 is induced during the macrophage inflammatory response
O'Connell, R. M., Taganov, K. D., Boldin, M. P., Cheng, G., & Baltimore, D. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0610731104 · Cited by 1,866 · cited 12×
“Northern blotting was performed as described (19) using a probe reverse complementary to the human miR-155 seed mutant (see Table S1).”
BackgroundMethodInfluentialSelf-citationRequirement of bic/microRNA-155 for Normal Immune Function
Rodriguez, A., Vigorito, E., Clare, S., Warren, M. V., Couttet, P., Soond, D. R., van Dongen, S., Grocock, R. J., Das, P. P., Miska, E. A., et al. (2007) · Science · doi:10.1126/science.1139253 · Cited by 1,833 · cited 4×
“MiRNA-155 is expressed in a variety of immune cell types, including B cells (8, 9, 13–17), T cells (18), macrophages (19, 20), dendritic cells (8), and progenitor/stem cell populations (7, 21).”
BackgroundInfluentialVentura, A., Young, A. G., Winslow, M. M., Lintault, L., Meissner, A., Erkeland, S. J., Newman, J., Bronson, R. T., Crowley, D., Stone, J. R., et al. (2008) · Cell · doi:10.1016/j.cell.2008.02.019 · Cited by 1,590
Regulation of the Germinal Center Response by MicroRNA-155
Thai, T.-H., Calado, D. P., Casola, S., Ansel, K. M., Xiao, C., Xue, Y., Murphy, A., Frendewey, D., Valenzuela, D., Kutok, J. L., et al. (2007) · Science · doi:10.1126/science.1141229 · Cited by 1,477 · cited 2×
“For example, defective germinal center formation and antibody isotype classswitching have been observed in miR-155 / mice following infection or vaccination (8, 9, 22).”
BackgroundMicromanagers of gene expression: the potentially widespread influence of metazoan microRNAs
Bartel, D. P., & Chen, C.-Z. (2004) · Nature Reviews Genetics · doi:10.1038/nrg1328 · Cited by 1,425
Accumulation of miR-155 and BIC RNA in human B cell lymphomas
Eis, P. S., Tam, W., Sun, L., Chadburn, A., Li, Z., Gomez, M. F., Lund, E., & Dahlberg, J. E. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0500613102 · Cited by 1,325
Xiao, C., Srinivasan, L., Calado, D. P., Patterson, H. C., Zhang, B., Wang, J., Henderson, J. M., Kutok, J. L., & Rajewsky, K. (2008) · Nature Immunology · doi:10.1038/ni1575 · Cited by 1,228 · cited 1×
“Similar observations have been made for specific targets of miR-150 (11, 50), miR-223 (6), and miR-17–92 (10, 12), suggesting a common theme of a few significant targets making dominant contributions to miRNA function.”
BackgroundRegulation of progenitor cell proliferation and granulocyte function by microRNA-223
Johnnidis, J. B., Harris, M. H., Wheeler, R. T., Stehling-Sun, S., Lam, M. H., Kirak, O., Brummelkamp, T. R., Fleming, M. D., & Camargo, F. D. (2008) · Nature · doi:10.1038/nature06607 · Cited by 1,208 · cited 1×
“Similar observations have been made for specific targets of miR-150 (11, 50), miR-223 (6), and miR-17–92 (10, 12), suggesting a common theme of a few significant targets making dominant contributions to miRNA function.”
BackgroundMicroRNAs: new regulators of immune cell development and function
Baltimore, D., Boldin, M. P., O'Connell, R. M., Rao, D. S., & Taganov, K. D. (2008) · Nature Immunology · doi:10.1038/ni.f.209 · Cited by 1,088
Self-citationMiR-150 Controls B Cell Differentiation by Targeting the Transcription Factor c-Myb
Xiao, C., Calado, D. P., Galler, G., Thai, T.-H., Patterson, H. C., Wang, J., Rajewsky, N., Bender, T. P., & Rajewsky, K. (2007) · Cell · doi:10.1016/j.cell.2007.07.021 · Cited by 1,042 · cited 1×
“Similar observations have been made for specific targets of miR-150 (11, 50), miR-223 (6), and miR-17–92 (10, 12), suggesting a common theme of a few significant targets making dominant contributions to miRNA function.”
Pre-B cell proliferation and lymphoblastic leukemia/high-grade lymphoma in Eμ-miR155 transgenic mice
Costinean, S., Zanesi, N., Pekarsky, Y., Tili, E., Volinia, S., Heerema, N., & Croce, C. M. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0602266103 · Cited by 951 · cited 1×
“found that transgenic expression of miR-155 from a B-cell specific promoter can trigger a B-cell malignancy (4).”
BackgroundLu, L.-F., Thai, T.-H., Calado, D. P., Chaudhry, A., Kubo, M., Tanaka, K., Loeb, G. B., Lee, H., Yoshimura, A., Rajewsky, K., et al. (2009) · Immunity · doi:10.1016/j.immuni.2008.11.010 · Cited by 783 · cited 4×
“SOCS1 targeting by miR-155 has just recently been shown to impact T-regulatory cell homeostasis (49).”
BackgroundInfluentialmicroRNA-155 Regulates the Generation of Immunoglobulin Class-Switched Plasma Cells
Vigorito, E., Perks, K. L., Abreu-Goodger, C., Bunting, S., Xiang, Z., Kohlhaas, S., Das, P. P., Miska, E. A., Rodriguez, A., Bradley, A., et al. (2007) · Immunity · doi:10.1016/j.immuni.2007.10.009 · Cited by 763 · cited 3×
“1 (22), AID (47, 48), SOCS1 (49), and now SHIP1, suggest that individual targets likely make significant contributions to miR-155 function in a context-dependent manner.”
BackgroundO'Connell, R. M., Rao, D. S., Chaudhuri, A. A., Boldin, M. P., Taganov, K. D., Nicoll, J., Paquette, R. L., & Baltimore, D. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20072108 · Cited by 681 · cited 10×
“Therefore, miR-155 repression of SHIP1 may prove to be a contributing factor to human MPDs and myeloid leukemias, where miR-155 has been shown to be over-expressed (7, 23).”
BackgroundMethodInfluentialSelf-citationKluiver, J., Poppema, S., de Jong, D., Blokzijl, T., Harms, G., Jacobs, S., Kroesen, B., & van den Berg, A. (2005) · The Journal of Pathology · doi:10.1002/path.1825 · Cited by 672
A viral microRNA functions as an orthologue of cellular miR-155
Gottwein, E., Mukherjee, N., Sachse, C., Frenzel, C., Majoros, W. H., Chi, J.-T. A., Braich, R., Manoharan, M., Soutschek, J., Ohler, U., et al. (2007) · Nature · doi:10.1038/nature05992 · Cited by 566
Helgason, C. D., Damen, J. E., Rosten, P., Grewal, R., Sorensen, P., Chappel, S. M., Borowski, A., Jirik, F., Krystal, G., & Humphries, R. K. (1998) · Genes & Development · doi:10.1101/gad.12.11.1610 · Cited by 556
Distinctive microRNA signature of acute myeloid leukemia bearing cytoplasmic mutated nucleophosmin
Garzon, R., Garofalo, M., Martelli, M. P., Briesewitz, R., Wang, L., Fernandez-Cymering, C., Volinia, S., Liu, C.-G., Schnittger, S., Haferlach, T., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0800135105 · Cited by 500 · cited 2×
“Enhanced expression of miR-155 occurs constitutively in a subset of cancer cells of lymphoid (13–17) and myeloid origin (7, 23).”
BackgroundQuantitative technologies establish a novel microRNA profile of chronic lymphocytic leukemia
Fulci, V., Chiaretti, S., Goldoni, M., Azzalin, G., Carucci, N., Tavolaro, S., Castellano, L., Magrelli, A., Citarella, F., Messina, M., et al. (2007) · Blood · doi:10.1182/blood-2006-12-062398 · Cited by 499
Georgantas, R. W., Hildreth, R., Morisot, S., Alder, J., Liu, C.-G., Heimfeld, S., Calin, G. A., Croce, C. M., & Civin, C. I. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0610983104 · Cited by 491 · cited 1×
“MiRNA-155 is expressed in a variety of immune cell types, including B cells (8, 9, 13–17), T cells (18), macrophages (19, 20), dendritic cells (8), and progenitor/stem cell populations (7, 21).”
BackgroundMicroRNA-155 Suppresses Activation-Induced Cytidine Deaminase-Mediated Myc-Igh Translocation
Dorsett, Y., McBride, K. M., Jankovic, M., Gazumyan, A., Thai, T.-H., Robbiani, D. F., Di Virgilio, M., San-Martin, B. R., Heidkamp, G., Schwickert, T. A., et al. (2008) · Immunity · doi:10.1016/j.immuni.2008.04.002 · Cited by 458 · cited 5×
“The AID studies also provide evidence that miR-155 targeting of AID impacts Ig class-switching and the rate of c-myc translocations in B lymphocytes.”
BackgroundInfluentialMicroRNA-155 Is a Negative Regulator of Activation-Induced Cytidine Deaminase
Teng, G., Hakimpour, P., Landgraf, P., Rice, A., Tuschl, T., Casellas, R., & Papavasiliou, F. N. (2008) · Immunity · doi:10.1016/j.immuni.2008.03.015 · Cited by 447 · cited 5×
“The AID studies also provide evidence that miR-155 targeting of AID impacts Ig class-switching and the rate of c-myc translocations in B lymphocytes.”
BackgroundInfluentialKaposi's Sarcoma-Associated Herpesvirus Encodes an Ortholog of miR-155
Skalsky, R. L., Samols, M. A., Plaisance, K. B., Boss, I. W., Riva, A., Lopez, M. C., Baker, H. V., & Renne, R. (2007) · Journal of Virology · doi:10.1128/jvi.01804-07 · Cited by 445
Micromanagement of the immune system by microRNAs
Lodish, H. F., Zhou, B., Liu, G., & Chen, C.-Z. (2008) · Nature Reviews Immunology · doi:10.1038/nri2252 · Cited by 438
p150Ship, a signal transduction molecule with inositol polyphosphate-5-phosphatase activity.
Lioubin, M. N., Algate, P. A., Tsai, S., Carlberg, K., Aebersold, A., & Rohrschneider, L. R. (1996) · Genes & Development · doi:10.1101/gad.10.9.1084 · Cited by 418
Liu, Q., Sasaki, T., Kozieradzki, I., Wakeham, A., Itie, A., Dumont, D. J., & Penninger, J. M. (1999) · Genes & Development · doi:10.1101/gad.13.7.786 · Cited by 341
MicroRNA-Mediated Control of Cell Fate in Megakaryocyte-Erythrocyte Progenitors
Lu, J., Guo, S., Ebert, B. L., Zhang, H., Peng, X., Bosco, J., Pretz, J., Schlanger, R., Wang, J. Y., Mak, R. H., et al. (2008) · Developmental Cell · doi:10.1016/j.devcel.2008.03.012 · Cited by 310 · cited 1×
“Similar observations have been made for specific targets of miR-150 (11, 50), miR-223 (6), and miR-17–92 (10, 12), suggesting a common theme of a few significant targets making dominant contributions to miRNA function.”
BackgroundPolycistronic RNA polymerase II expression vectors for RNA interference based on BIC/miR-155
Chung, K.-H. (2006) · Nucleic Acids Research · doi:10.1093/nar/gkl143 · Cited by 306 · cited 1×
“Knockdown of other genes in vitro has been shown using this approach (29).”
BackgroundTam, W., Ben-Yehuda, D., & Hayward, W. S. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.3.1490 · Cited by 285
Yin, Q., McBride, J., Fewell, C., Lacey, M., Wang, X., Lin, Z., Cameron, J., & Flemington, E. K. (2008) · Journal of Virology · doi:10.1128/jvi.02380-07 · Cited by 261 · cited 1×
“It is also plausible that virally encoded orthologs of miR-155 (42–44), or miR-155 induction by viruses such as Epstein-Barr virus (45), can decrease SHIP1 expression en route to B-cell activation and Fig.”
BackgroundHigh expression of B‐cell receptor inducible gene BIC in all subtypes of Hodgkin lymphoma
van den Berg, A., Kroesen, B., Kooistra, K., de Jong, D., Briggs, J., Blokzijl, T., Jacobs, S., Kluiver, J., Diepstra, A., Maggio, E., et al. (2003) · Genes, Chromosomes and Cancer · doi:10.1002/gcc.10186 · Cited by 232
Liu, Q., Oliveira-Dos-Santos, A. J., Mariathasan, S., Bouchard, D., Jones, J., Sarao, R., Kozieradzki, I., Ohashi, P. S., Penninger, J. M., & Dumont, D. J. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.7.1333 · Cited by 206 · cited 2×
“As miR-155 levels are elevated in certain B-cell lymphomas (13–17), and because SHIP1 is a negative regulator of B-cell activation and survival (30, 35, 36), the miR-155-SHIP1 axis should also prove to be of relevance to B-cell malignancies.”
BackgroundHaasch, D., Chen, Y.-W., Reilly, R. M., Grace Chiou, X., Koterski, S., Smith, M. L., Kroeger, P., McWeeny, K., Halbert, D. N., Mollison, K. W., et al. (2002) · Cellular Immunology · doi:10.1016/s0008-8749(02)00506-3 · Cited by 189
A Dual Role for Src Homology 2 Domain–Containing Inositol-5-Phosphatase (Ship) in Immunity
Helgason, C. D., Kalberer, C. P., Damen, J. E., Chappel, S. M., Pineault, N., Krystal, G., & Humphries, R. K. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.5.781 · Cited by 147
A Functional MicroRNA-155 Ortholog Encoded by the Oncogenic Marek's Disease Virus
Zhao, Y., Yao, Y., Xu, H., Lambeth, L., Smith, L. P., Kgosana, L., Wang, X., & Nair, V. (2009) · Journal of Virology · doi:10.1128/jvi.01166-08 · Cited by 142
Possible dominant-negative mutation of the SHIP gene in acute myeloid leukemia
Luo, J.-M., Yoshida, H., Komura, S., Ohishi, N., Pan, L., Shigeno, K., Hanamura, I., Miura, K., Iida, S., Ueda, R., et al. (2003) · Leukemia · doi:10.1038/sj.leu.2402725 · Cited by 127
The role of SHIP in cytokine-induced signaling
Kalesnikoff, J., Sly, L. M., Hughes, M. R., Büchse, T., Rauh, M. J., Cao, L.-P., Lam, V., Mui, A., Huber, M. C., & Krystal, G. (2003) · Springer eBooks · doi:10.1007/s10254-003-0016-y · Cited by 116 · cited 1×
“This condition is thought to occur as a result of its role as a negative regulator of signaling by growth factors and other immune receptors (30, 34).”
BackgroundSly, L. M., Rauh, M. J., Kalesnikoff, J., Büchse, T., & Krystal, G. (2003) · Experimental Hematology · doi:10.1016/j.exphem.2003.09.011 · Cited by 116
Harder, K. W., Quilici, C., Naik, E., Inglese, M., Kountouri, N., Turner, A., Zlatic, K., Tarlinton, D. M., & Hibbs, M. L. (2004) · Blood · doi:10.1182/blood-2003-12-4396 · Cited by 102
The termination of PI3K signalling by SHIP1 and SHIP2 inositol 5-phosphatases
Backers, K., Bléro, D., Paternotte, N., Zhang, J., & Erneux, C. (2003) · Advances in Enzyme Regulation · doi:10.1016/s0065-2571(02)00043-2 · Cited by 98
Tarasenko, T., Kole, H. K., Chi, A. W., Mentink-Kane, M. M., Wynn, T. A., & Bolland, S. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0704853104 · Cited by 97 · cited 1×
“Furthermore, knockout of SHIP1 in B lymphocytes causes spontaneous germinal center formation and antibody class-switching (30, 35, 36), while a SHIP deficiency in T cells skews peripheral T lymphocytes toward Th1 and away from Th2 in response to an immune challenge (37).”
BackgroundLeung, W.-H., Tarasenko, T., & Bolland, S. (2009) · Immunologic Research · doi:10.1007/s12026-008-8078-1 · Cited by 49 · cited 4×
“As miR-155 levels are elevated in certain B-cell lymphomas (13–17), and because SHIP1 is a negative regulator of B-cell activation and survival (30, 35, 36), the miR-155-SHIP1 axis should also prove to be of relevance to B-cell malignancies.”
BackgroundInfluentialMutation analysis of SHIP gene in acute leukemia.
Luo, J., Liu, Z., Hao, H.-L., Wang, F., Dong, Z.-R., & Ryuzo, O. (2004) · PubMed · Cited by 49
Homeostasis and regeneration of the hematopoietic stem cell pool are altered in SHIP-deficient mice
Helgason, C. D., Antonchuk, J., Bodner, C., & Humphries, R. K. (2003) · Blood · doi:10.1182/blood-2002-12-3939 · Cited by 47
Chen, L., Cui, B., Zhang, S., Chen, G. T., Croce, C. M., & Kipps, T. J. (2008) · Blood · doi:10.1182/blood.v112.11.3155.3155 · Cited by 5 · cited 1×
“Two recent abstracts suggest that this is the case (40, 41).”
BackgroundOnco-Mir-155 Targets SHIP to Regulate TNF-Dependent B-Cell Lymphoma Growth
Pedersen, I. M., Otero, D. C., Kao, E., Sedy, A., Hother, C. E., Ralfkiaer, E. M., Rickert, R. C., Grønbæk, K., & David, M. (2008) · Blood · doi:10.1182/blood.v112.11.604.604 · Cited by 3 · cited 1×
“Two recent abstracts suggest that this is the case (40, 41).”
Background
Cited by
MicroRNA therapeutics: towards a new era for the management of cancer and other diseases
Rupaimoole, R., & Slack, F. J. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.246 · Cited by 4,741
Bartel, D. P. (2018) · Cell · doi:10.1016/j.cell.2018.03.006 · Cited by 3,751
“, 2011); perturbed function of macrophages and mast cells (O’Connell et al., 2009; Qayum et al., 2016); altered pathology in >60 disease/injury models”
BackgroundTrained immunity: A program of innate immune memory in health and– disease
Netea, M. G., Joosten, L. A. B., Latz, E., Mills, K. H. G., Natoli, G., Stunnenberg, H. G., O’Neill, L. A. J., & Xavier, R. J. (2016) · Science · doi:10.1126/science.aaf1098 · Cited by 2,768
“Among miRNAs, miR-155 may have particular relevance because its up-regulation in response to inflammatory signals such as microbial components is associated with the hyperactivation of myeloid cells, possibly due to the derepression of phosphatases that negatively regulate transducers of several signaling pathways (88…”
BackgroundDefining trained immunity and its role in health and disease
Netea, M. G., Domínguez-Andrés, J., Barreiro, L. B., Chavakis, T., Divangahi, M., Fuchs, E., Joosten, L. A. B., van der Meer, J. W. M., Mhlanga, M. M., Mulder, W. J. M., et al. (2020) · Nature Reviews Immunology · doi:10.1038/s41577-020-0285-6 · Cited by 2,690
Diversity, Mechanisms, and Significance of Macrophage Plasticity
Locati, M., Curtale, G., & Mantovani, A. (2020) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathmechdis-012418-012718 · Cited by 2,199
“O'Connell RM, Chaudhuri AA, Rao DS, Baltimore D. Inositol phosphatase SHIP1 is a primary target of miR-155.”
BackgroundInfluential
Metadata
- Authors
- O'Connell, R. M., Chaudhuri, A. A., Rao, D. S., & Baltimore, D.
- Affiliations
- Division of Biology, California Institute of Technology, 330 Braun, 1200 East California Boulevard, Pasadena, CA 91125; and
- California Institute of Technology (US)
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2009-04-28
- Volume
- 106
- Issue
- 17
- Pages
- 7113-7118
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC2678424
- OpenAlex
- W1974102799
- Cited by
- 826
- References
- 51
- Citations by year
- 2026: 19 · 2025: 22 · 2024: 28 · 2023: 47 · 2022: 34 · 2021: 32 · 2020: 45 · 2019: 42 · 2018: 37 · 2017: 50 · 2016: 67 · 2015: 70 · 2014: 65 · 2013: 85 · 2012: 73
- FWCI
- 20.36
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- CaltechAUTHORS (California Institute of Technology) (submittedVersion)
- Funders
- National Institute of Allergy and Infectious Diseases (R01AI079243)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › MicroRNA in disease regulation
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Keywords
- miR-155, SHIP1, inositol polyphosphate 5-phosphatase, microRNA target regulation, 3' UTR binding, hematopoiesis, macrophages, myeloproliferative neoplasms, microRNA knockdown, immune regulation
- MeSH terms
- Inositol Polyphosphate 5-Phosphatases, Phosphatidylinositol-3,4,5-Trisphosphate 5-Phosphatases, Animals, Base Sequence, Cell Line, Humans, Lipopolysaccharides, Phosphoric Monoester Hydrolases, Sequence Alignment, 3' Untranslated Regions, MicroRNAs, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.